Market Exclusive

Evolent Health, Inc. (NYSE:EVH) Files An 8-K Financial Statements and Exhibits

Evolent Health, Inc. (NYSE:EVH) Files An 8-K Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits

(a) Financial Statements of Business Acquired.
The audited financial statements of Valence as of December 31,
2015, and for the year ended December 31, 2015, are filed
herewith as Exhibit 99.1. The unaudited financial statements of
Valence as of September 30, 2016, and for the nine months ended
September 30, 2016 and 2015, are filed herewith as Exhibit 99.2.
The consent of KPMG LLP, Valence’s independent auditors, is
attached as Exhibit 23.1 to this Form 8-K/A.
(b) Pro Forma Financial Information.
The unaudited pro forma condensed combined financial information
of the Company and Valence for the year ended December 31, 2015,
and as of September 30, 2016, and for the nine months ended
September 30, 2016, are filed herewith as Exhibit 99.3
(d) Exhibits
Exhibit
Number
Description
23.1
Consent of KPMG LLP, Independent Auditors of Valence
Health, Inc.
99.1
Audited financial statements of Valence Health, Inc.,
excluding Cicerone Health Solutions, Inc. as of
December 31, 2015 and for the year ended December 31,
2015
99.2
Unaudited financial statements of Valence Health, Inc.
excluding Cicerone Health Solutions, Inc. as of
September 30, 2016, and for the nine months ended
September 30, 2016 and 2015
99.3
Unaudited pro forma condensed combined financial
information of the Company and Valence Health Inc., for
the year
ended December 31, 2015, and as of September 30, 2016,
and for the nine months ended September 30, 2016

About Evolent Health, Inc. (NYSE:EVH)
Evolent Health, Inc. supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services. Together these services enable health systems to manage patients’ health. It provides an end-to-end, built-for-purpose, technology-enabled services platform for providers in value-based payment models. Its platform supports a diverse set of provider value-based care strategies. It provides the technology and services necessary for the models pursued by providers. The Company offers Identifi, a technology platform that aggregates and analyzes data, manages care workflows and engages patients. Its Value-Based Operations are empowered and supported by Identifi. Evolent Health, Inc. (NYSE:EVH) Recent Trading Information
Evolent Health, Inc. (NYSE:EVH) closed its last trading session down -0.40 at 16.30 with 777,155 shares trading hands.

Exit mobile version